From the publishers of JADPRO

Chronic Lymphocytic Leukemia Resource Center

Advertisement
Videos
Interview with Lisa Nodzon, PhD, APRN, AOCNP: Expert Perspectives on Richter Transformation
Interview with Lisa Nodzon, PhD, APRN, AOCNP: Expert Perspectives on Richter Transformation
Interview with Josie Montegaard, NP: Supportive Care Considerations for Patients with CLL
Interview with Josie Montegaard, NP: Supportive Care Considerations for Patients with CLL
Interview With Kaitlyn Buhlinger, PharmD, CPP: A Pharmacist's Perspective on Common Questions in CLL
Interview With Kaitlyn Buhlinger, PharmD, CPP: A Pharmacist's Perspective on Common Questions in CLL
Interview With Brian Koffman, MDCM (retired), DCFP, FCFP, DABFP, MSEd: A Patient's Journey to Advocacy
Interview With Brian Koffman, MDCM (retired), DCFP, FCFP, DABFP, MSEd: A Patient's Journey to Advocacy
Interview with Michael Conte, PA-C: Choosing Frontline Therapy for CLL
Interview with Michael Conte, PA-C: Choosing Frontline Therapy for CLL
Interview With Christopher D'Andrea, PA-C: Initial Diagnosis of CLL
Interview With Christopher D'Andrea, PA-C: Initial Diagnosis of CLL
Advertisement
Case Studies

Richter Transformation to Hodgkin Lymphoma 

Measurable Residual Disease With Time-limited Venetoclax-based Regimens: Clinical Standards, Nuances

Venetoclax Alone and In Combination: Overcoming Ibrutinib Resistance 

Advertisement
Quizzes
Test your knowledge on CLL and Richter transformation
Test your knowledge on progressive disease after treatment with both a BTK Inhibitor and BCL2 Inhibitor 
Test your knowledge on measurable residual disease with time-limited Venetoclax-based regimens